SunLink Health Systems Inc (SSY) - Cash Flow Conversion Efficiency

Latest as of March 2025: -0.190x

Based on the latest financial reports, SunLink Health Systems Inc (SSY) has a cash flow conversion efficiency ratio of -0.190x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.54 Million) by net assets ($13.41 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

SunLink Health Systems Inc - Cash Flow Conversion Efficiency Trend (1991–2024)

This chart illustrates how SunLink Health Systems Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read SSY total liabilities for a breakdown of total debt and financial obligations.

SunLink Health Systems Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of SunLink Health Systems Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Profusa, Inc. Common Stock
NASDAQ:PFSA
0.313x
LCK Global Kedaton
JK:LCKM
0.002x
Moonpig Group PLC
LSE:MOON
-0.276x
ClearOne Inc
NASDAQ:CLRO
-0.218x
Norfolk Metals Ltd
AU:NFL
0.023x
Arb Bhd
KLSE:7181
-0.071x
Lifecare AS
OL:LIFE
3.325x
IMPRENDIROMA S.P.A.
F:Y37
N/A

Annual Cash Flow Conversion Efficiency for SunLink Health Systems Inc (1991–2024)

The table below shows the annual cash flow conversion efficiency of SunLink Health Systems Inc from 1991 to 2024. For the full company profile with market capitalisation and key ratios, see SunLink Health Systems Inc (SSY) total market value.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-06-30 $15.97 Million $-2.98 Million -0.186x -501.34%
2023-06-30 $17.42 Million $-540.00K -0.031x -14720.00%
2022-06-30 $19.12 Million $-4.00K 0.000x -100.32%
2021-06-30 $20.81 Million $1.36 Million 0.066x -77.29%
2020-06-30 $13.74 Million $3.97 Million 0.289x +404.45%
2019-06-30 $15.04 Million $-1.43 Million -0.095x -511.69%
2018-06-30 $17.19 Million $396.00K 0.023x +108.91%
2017-06-30 $21.69 Million $-5.61 Million -0.259x -1083.10%
2016-06-30 $19.49 Million $-426.00K -0.022x -124.97%
2015-06-30 $33.56 Million $2.94 Million 0.088x -25.06%
2014-06-30 $33.32 Million $3.89 Million 0.117x +295.52%
2013-06-30 $33.74 Million $-2.02 Million -0.060x -156.78%
2012-06-30 $29.29 Million $3.08 Million 0.105x -30.74%
2011-06-30 $31.46 Million $4.78 Million 0.152x +65.12%
2010-06-30 $42.69 Million $3.93 Million 0.092x -11.95%
2009-06-30 $42.39 Million $4.43 Million 0.105x +154.15%
2008-06-30 $40.86 Million $1.68 Million 0.041x -68.81%
2007-06-30 $36.02 Million $4.75 Million 0.132x +0.50%
2006-06-30 $34.35 Million $4.51 Million 0.131x +72.74%
2005-06-30 $29.30 Million $2.23 Million 0.076x +171.09%
2004-06-30 $24.90 Million $-2.66 Million -0.107x -384.52%
2003-06-30 $6.47 Million $243.00K 0.038x -93.64%
2002-06-30 $5.96 Million $3.51 Million 0.590x +535.83%
2001-06-30 $9.63 Million $-1.30 Million -0.135x +65.66%
2000-06-30 $9.51 Million $-3.75 Million -0.394x -392.88%
1999-06-30 $7.50 Million $-600.00K -0.080x -118.56%
1998-06-30 $18.10 Million $7.80 Million 0.431x +158.56%
1997-06-30 $18.00 Million $3.00 Million 0.167x -3.33%
1996-06-30 $14.50 Million $2.50 Million 0.172x +102.59%
1995-06-30 $14.10 Million $1.20 Million 0.085x +125.53%
1994-06-30 $10.60 Million $400.00K 0.038x -91.31%
1993-06-30 $9.90 Million $4.30 Million 0.434x +64.09%
1992-06-30 $10.20 Million $2.70 Million 0.265x -33.82%
1991-06-30 $8.50 Million $3.40 Million 0.400x --

About SunLink Health Systems Inc

NYSE MKT:SSY USA Pharmaceutical Retailers
Market Cap
$7.85 Million
Market Cap Rank
#27431 Global
#5432 in USA
Share Price
$1.12
Change (1 day)
+16.15%
52-Week Range
$0.83 - $1.36
All Time High
$4.85
About

As of August 14, 2025, SunLink Health Systems, Inc. was acquired by Regional Health Properties, Inc. SunLink Health Systems, Inc., through its subsidiaries, provides healthcare products and services in the southeastern United States. The company operates through Healthcare Services and Pharmacy segments. It is also involved in provision of specialty and non-specialty pharmaceutical and biological… Read more